Consolidated Statements of Changes in Stockholders' Equity Deficiency - USD ($)	Total	$0.01 Par Value Common Stock	Additional Paid-In Capital	Accumulated Deficiency
Beginning Balance at Dec. 31, 2013	$ (2,088,549)	$ 432,231	$ 6,679,298	$ (9,200,078)
Beginning Balance, shares at Dec. 31, 2013		43,223,093
Stock-based compensation	$ 294,067		$ 294,067
Return of unvested consultant stock	(45,000)	$ (5,000)	(40,000)
Return of unvested consultant stock, shares		(500,000)
Issuance of common stock	$ 25,000	$ 883	$ 24,167
Issuance of common stock, shares		83,334
Exercise of common stock options	$ 22,500	$ 1,125	$ 21,375
Exercise of common stock options, shares		112,500
Net loss	(1,537,315)			$ (1,537,315)
Ending Balance at Dec. 31, 2014	$ (3,329,297)	$ 429,189	$ 6,978,907	$ (10,737,393)
Ending Balance, shares at Dec. 31, 2014		42,918,927
Stock-based compensation	$ 192,776		$ 192,776
Net loss	(2,743,116)			$ (2,743,116)
Ending Balance at Dec. 31, 2015	$ (5,879,637)	$ 429,189	$ 7,171,683	$ (13,480,509)
Ending Balance, shares at Dec. 31, 2015		42,918,927